Cargando…

Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review

AIMS: While mexiletine has been used for over 40 years for prevention of (recurrent) ventricular arrhythmias and for myotonia, patient access has recently been critically endangered. Here we aim to demonstrate the effectiveness and safety of mexiletine in the treatment of patients with (recurrent) v...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Ree, Martijn H, van Dussen, Laura, Rosenberg, Noa, Stolwijk, Nina, van den Berg, Sibren, van der Wel, Vincent, Jacobs, Bart A W, Wilde, Arthur A M, Hollak, Carla E M, Postema, Pieter G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681134/ https://www.ncbi.nlm.nih.gov/pubmed/36036670 http://dx.doi.org/10.1093/europace/euac087

Ejemplares similares

Access to medicines for rare diseases: A European regulatory roadmap for academia
por: Rosenberg, Noa, et al.
Publicado: (2023)

Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome
por: Yang, Jing, et al.
Publicado: (2022)

Registries for orphan drugs: generating evidence or marketing tools?
por: Hollak, Carla E. M., et al.
Publicado: (2020)

Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial
por: van der Ree, Martijn H, et al.
Publicado: (2023)

Outcomes in Dutch DPP6 risk haplotype for familial idiopathic ventricular fibrillation: a focused update
por: Bergeman, Auke T., et al.
Publicado: (2023)

Left Axis Deviation in Brugada Syndrome: Vectorcardiographic Evaluation during Ajmaline Provocation Testing Reveals Additional Depolarization Abnormalities
por: van der Ree, Martijn H., et al.
Publicado: (2021)

Genetic Basis of Ventricular Arrhythmias
por: Pazoki, Raha, et al.
Publicado: (2010)

Management of ventricular tachycardia--role of mexiletine : proceedings of a symposium held in Copenhagen, Denmark, 25th-27th May, 1978 /
Publicado: (1978)

Drug Repurposing for Rare Diseases: A Role for Academia
por: van den Berg, Sibren, et al.
Publicado: (2021)

Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia
por: Peltenburg, Puck J, et al.
Publicado: (2022)

Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardia
por: van der Ree, Martijn H., et al.
Publicado: (2023)

Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium
por: Hézső, Tamás, et al.
Publicado: (2021)

The β-angle can help guide clinical decisions in the diagnostic work-up of patients suspected of Brugada syndrome: a validation study of the β-angle in determining the outcome of a sodium channel provocation test
por: van der Ree, Martijn H, et al.
Publicado: (2021)

A patient with mexiletine-related psychosis
por: Shailesh, Fnu, et al.
Publicado: (2011)

Pharmacological treatment of short-coupled idiopathic ventricular fibrillation: A review
por: Bergeman, A.T., et al.
Publicado: (2023)

Interobserver variability in target definition for stereotactic arrhythmia radioablation
por: van der Ree, Martijn H., et al.
Publicado: (2023)

Experience with oral mexiletine in primary erythromelalgia in children
por: Iqbal, Javeed, et al.
Publicado: (2009)

Molecular Modeling of Cardiac Sodium Channel with Mexiletine
por: Zhorov, Boris S.
Publicado: (2022)

Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease
por: van Dussen, Laura, et al.
Publicado: (2014)

Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications
por: van Dussen, Laura, et al.
Publicado: (2014)

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy( )
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2022)

Analysis of 24-h Rhythm in Ventricular Repolarization Identifies QT Diurnality As a Novel Clinical Parameter Associated with Previous Ventricular Arrhythmias in Heart Failure Patients
por: Du Pre, Bastiaan C., et al.
Publicado: (2017)

Characterisation of mexiletine’s translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart
por: Hesketh, Louise M., et al.
Publicado: (2020)

The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overview
por: Verheul, Lisa M, et al.
Publicado: (2023)

A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation
por: Zakrzewska‐Koperska, Joanna, et al.
Publicado: (2020)

Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction
por: Verstraelen, Tom E, et al.
Publicado: (2021)

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation
por: Liu, Guizhi, et al.
Publicado: (2017)

Stereotactic arrhythmia radiotherapy for ventricular tachycardia does not appear to alter QRS duration and QTc interval: a secondary analysis of the prospective STARNL-1 trial
por: Hoeksema, W F, et al.
Publicado: (2023)

Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol
por: Stunnenberg, Bas C, et al.
Publicado: (2015)

Retracted and Republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2019)

Curative Effect of Yangxin Dingji Capsule Combined With Mexiletine Hydrochloride on Postoperative Arrhythmia and Its Influences on the Vascular Endothelial Function in Coronary Bifurcation Lesions
por: Sun, Nasha, et al.
Publicado: (2022)

Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
por: Hindi-Assaf, A, et al.
Publicado: (2023)

Recurrent metabolic alkalosis following ketone body treatment of adult mitochondrial trifunctional protein deficiency: A case report
por: Stolwijk, Nina N., et al.
Publicado: (2022)

Standardizing the Cardiac Radioablation Targeting Workflow: Enabling Semi-Automated Angulation and Segmentation of the Heart According to the American Heart Association Segmented Model
por: van der Ree, Martijn H., et al.
Publicado: (2022)

ECG Changes during Adult Life in Fabry Disease: Results from a Large Longitudinal Cohort Study
por: El Sayed, Mohamed, et al.
Publicado: (2023)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia
por: Lee, Sang-Pyo, et al.
Publicado: (2010)

Therapeutic drug monitoring of mexiletine at a large academic medical center
por: Nei, Scott D, et al.
Publicado: (2016)

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
por: Yamada, Shinichiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5qj8728gcsol0s5qt067535n4e